Products


Products under patent are available for R&D in the USA as permitted under 35 USC ยง 271(e)(1)

  • Abaloparatide
  • Abiraterone Acetate
  • Acrivastine
  • Axitinib
  • Azilsartan Medoxomil Potassium
  • Baricitinib
  • Brexpiprazole
  • Brivaracetam
  • Cabozantinib
  • Carfilzomib
  • Cobicistat
  • Crisaborole
  • Dolutegravir
  • Edoxaban Tosylate
  • Empagliflozin
  • Enzalutamide
  • Eplerenone
  • Etelcalcetide
  • Fingolimod Hydrochloride
  • Fulvestrant
  • Hydrocortisone Acetate
  • Ibrutinib
  • Icosapent Ethyl
  • Ivabradine Hydrochloride (Alpha Form, Delta Form)
  • Ivacaftor
  • Ixazomib Citrate
  • Ledipasvir
  • Lenalidomide
  • Lenvatinib Mesylate
  • Linagliptin
  • Lumacaftor
  • Luprostiol
  • Lurasidone
  • Macitentan
  • Methylprednisolone Acetate Sterile
  • Mirabegron
  • Niraparib
  • Obeticholic Acid
  • Olaparib
  • Olodaterol
  • Osimertinib Mesylate
  • Ozanimod
  • Palbociclib
  • Panobinostat Lactate
  • Pirfenidone
  • Plecanatide
  • Prednisolone Acetate Sterile
  • Pregabalin
  • Ribociclib
  • Riociguat
  • Rosuvastatin Calcium
  • Rucaparib Camsylate
  • Sacubitril
  • Sacubitril and Valsartan
  • Sacubitril Sodium
  • Selexipag
  • Sofosbuvir
  • Sorafenib
  • Teduglutide (Recombinant)
  • Tenofovir Disoproxil Fumarate
  • Tiaprost
  • Ticagrelor
  • Tipiracil
  • Tofacitinb Citrate
  • Unoprostone
  • Valsartan/Sacubitril (LCZ696)
  • Velpatasvir
  • Venetoclax
  • Vilanterol
  • Vortioxetine